**CURRICULUM VITA**

June 2003

**Name**: Michael Gough

**Education**: B.A., Biology, Grinnell College, 1961

Ph.D., Biology, Brown University, 1966

**Honors**:

1958 - 1961 George C. Baker National Scholar at Grinnell College

1963 - 1965 U.S. Public Health Service Predoctoral Fellow

1965 Elected to full membership in Sigma Xi

1969 American Men and Women of Science

1970 Offered membership in New York Academy of Sciences

1971 Fulbright Lecturer, Universidad Peruana \"Cayetano Heredia\" Lima,
Peru

1974 Who\'s Who in the East

1975 Fulbright Lecturer, Indian Institute of Science, Bangalore, India,
and University of Madurai, Madurai, India

1987 *Choice*, a library journal, named *Dioxin, Agent Orange* one of
the \"most outstanding academic books\" of the year

1995. Certificate of Appreciation, Department of Health and Human
      Services for chairing the HHS committee to review the Air Force's
      study of the health of men who sprayed Agent Orange

1996. Elected Fellow of the Society for Risk Analysis

2001 - 2002 President, International Society of Regulatory Toxicology
and

> Pharmacology

**Research Funding**:

1968 - 1976 Grants from U.S. Public Health Service, American Cancer
Society, and National Science Foundation

**Experience**:

1965 - 1968 Postdoctoral Fellow

Department of Human Genetics

University of Michigan - Laboratory of Prof. Myron Levine

1968 - 1972 Assistant Professor

Department of Microbiology

Baylor College of Medicine

Houston, Texas

1972 - 1976 Assistant then Associate Professor

Department of Microbiology

State University of New York

Stony Brook, New York

1976 - 1978 Administrative Positions

National Institutes of Health

Bethesda, Maryland

9/78 - 10/85 Senior Analyst/Senior Associate

Office of Technology Assessment

U.S. Congress

Washington, DC 20510

11/85 - 4/86 Director

Risk Science Institute

Washington, DC 20036

4/86 - 10/87 Project Manager

ENVIRON Corporation

Washington, DC 20007

10/87 - 3/90 Senior Fellow

Center for Risk Management

Resources for the Future

Washington, DC 20036

3/90 - 10/90 Director

Center for Risk Management

Resources for the Future

Washington, DC 20036

10/90 - 3/94 Manager

Biological and Behavioral Sciences Program

Office of Technology Assessment

U.S. Congress

3/94 - 9/95 Senior Associate

Office of Technology Assessment

U.S. Congress

(Congress voted against funding OTA after September 30, 1995.)

10-11/95 Visiting Scholar

Center for Technology Assessment in Baden-Wurttemberg

Stuttgart, Germany

1/96-1/99 Director

Science and Risk Studies

Cato Institute

Washington, DC

Current Consultant

**Liaison and Advisory Positions**:

1/80 - 10/85 OTA Liaison

Agent Orange Working Group

Executive Office of the President

1/80 - 10/85 Member, Science Panel

Agent Orange Working Group

Executive Office of the President

1/80 - 10/85 OTA Liaison

National Council on Radiation Protection and Measurements

9/80 - 5/81 Associate

Department of Health Services Administration

The Johns Hopkins School of Hygiene and Public Health

Baltimore, Maryland

12/82 - 3/84 Member of Executive Committee

Consensus Workshop on Formaldehyde

National Center for Toxicological Research

1984 - 1994 Consultant

Science Advisory Board

Environmental Protection Agency

11/85 - 9/90 Member

Agent Orange Advisory Panel and

Advisory Panel on Health Effects Studies in Atomic Veterans

Office of Technology Assessment

1986 - 1987 Member

Risk Assessment Advisory Board

General Accounting Office

\[Product: *Health Risk Analysis: Technical Adequacy in Three Selected
Cases.* GAO, 1987\]

12/87 - 9/90 Chair

Advisory Committee on the Health-Related Effects of Herbicides

U.S. Department of Veterans Affairs

1988 -1989 Member

Committee on Risk Communication

American Chemical Society

1988 Member

Workshop on Risk Perception

American Medical Association

1988 - 1995 Editorial Board

*Risk Analysis*

1990 - 1995 Chair

Advisory Committee on Special Studies Relating to the

Possible Long-Term Health Effects of Phenoxy

Herbicides and Contaminants (Ranch Hand Advisory Committee)

U.S. Department of Health and Human Services

1995 Member

Dioxin Reassessment Review Committee

Science Advisory Board

U.S. Environmental Protection Agency

1997-2002 Board of Scientific and Policy Advisors

> American Council on Science and Health
>
> New York

1997- 2002 Advisory Council

Atlantic Legal Foundation

New York

1997- 2002 Academic Member

> European Science and Environment Forum
>
> London, England

1997-1998 Board of Directors

> The Advancement of Sound Science Coalition
>
> Washington, DC

1997. Editorial Board

## Regulatory Toxicology and Pharmacology

1999-2000 Vice-President

> International Society of Regulatory Toxicology and Pharmacology

1998. Associate Editor

## Regulatory Toxicology and Pharmacology

9/2000- Member,

Advisory Committee on Special Studies Relating to the

Possible Long-Term Health Effects of Phenoxy

Herbicides and Contaminants (Ranch Hand Advisory Committee)

U.S. Department of Health and Human Services

2001-2002 President

International Society of Regulatory Toxicology and Pharmacology

**PUBLICATIONS**

**[Basic Science]{.underline}**

Gough, M. and S. Lederberg. 1966. Methylated bases in the host-modified
deoxyribonucleic acid of *Echerichia coli* and bacteriophage λ. *J.
Bacteriol. 91*:1460.

Gough, M. and M. Levine. 1968. The circular genetic map of *Salmonella
typhimurium* phage P22. *Genetics 58*:161.

Gough, M. 1968. A second locus of phage P22 necessary for the
maintenance of lysogeny. *J. Virology 2*:992.

Gough, M. 1969. Thermal reversal of UV irradiation damage in *Salmonella
typhimurium. J. Bacteriol. 99*:350.

Gough, M. 1970. Requirement for a functional [int]{.underline} product
in temperature inductions of prophage P22 *ts mnt. J. Virology 6*:320.

Gough, M., J.V. Scott, V.A. Malik, and O. dela Rosa. 1972. Host
morphology and phage DNA synthesis following exposure of *Salmonella
typhimurium* (P22 *mnt ts* 1) to high temperature. *Virology 47*:276.

Gough, M. and J.V. Scott. 1972. Location of the prophage conversion gene
of P22. *Virology 50*:603.

Guerra, H., M. Gough, and R.P. Williams. 1972. Development of techniques
for obtaining viable radioactive *Brucellae* and detecting them in
tissues of infected guinea pigs. In *Radioactive Tracers in Microbial
Immunity*. International Atomic Energy Agency: Vienna. Pp. 111-123.

Douglas, R.G., R.B. Couch, B.D. Baxter, and M. Gough. 1974. Attenuation
of rhinovirus type 15: Relation of illness to plaque size. *Infection
and Immunity. 9*:519.

Tokuno, S-I., E. Goldschmidt, and M. Gough. 1974. A mutant of
*Salmonella typhimurium* which channels infecting P22 toward
lysogenization. *J. Bacteriol. 119*:508.

Gough, M. and S-I. Tokuno. 1975. Further structural and functional
analogies between the repressor regions of phages P22 and λ. *Molec.
General Genetic 138*:71.

Tokuno, S-I. and M. Gough. 1975. Host influence on the activity of genes
*c*1 and *c*3 in regulating the decision between lysis and lysogeny in
phage P22. *J. Virology 16*:1184.

Tokuno, S-I. and M. Gough. 1976. UV inactivation of a nonrespressor
regulatory protein of phage P22. *J. Virology 18*:65.

Tokuno, S-I. and M. Gough. 1976. Function of P22 site *c*27 and positive
and negative control of the pathway to lysogeny. *Molec. General
Genetics 144*:199.

Steinberg, B. and M. Gough. 1976. Bacteriophage P22 lysogenizes at high
multiplicities of infection because *Salmonella typhimurium* DNA
synthetic capacity is limited. *Nature 263*:54.

Tokuno, S-I. and M. Gough. 1977. Regulation of P22 DNA synthesis and
repressor levels in P22 [cly]{.underline} infections. *J. Virology
21*:956.

Tokuno, S-I., L. Roth, C. Weinberger, and M. Gough. 1977. Effect of
mutant host RNA polymerase on the bifunctional activities of P22 gene
*c*1. *Molec. General Genetics 153*:205.

Gough, M. 1977. Establishment mode repressor synthesis blunts P22
antirepressor activity. *J. Molec. Biol. 111*:55.

**[Technology Assessment, Risk Assessment and Public
Policy]{.underline}**

**[Books]{.underline}**

Gough, M. 1986. *Dioxin, Agent Orange: The Facts*. Plenum Press: New
York \[Second printing, 1987\].

Glickman, T.S. and M. Gough (eds.). 1990. *Readings in Risk.* Johns
Hopkins University Press: Baltimore, MD \[Second printing, 1991\].

Milloy, S.J. and M. Gough. 1999. *Silencing Science*. Cato Institute:
Washington.

### Commercial Reprints of OTA Reports

*Cancer Risk: Assessing and Reducing the Dangers in Our Society*.
Westview Press: Boulder, CO, 1981. \[A commercial reprint of the OTA
1981 report *Assessment of Technologies for Determining Cancer Risks
From the Environment*.\]

*Preventing Illness and Injury in the Workplace*. UNIPUB, InfoSource
International: New York, 1985. \[A commercial reprint of the OTA 1985
report of the same name.\]

*Assessment of Technologies for Determining Human Mutation Rates*. J.B.
Lippincott: Philadelphia, 1988. \[A commercial reprint of the OTA 1987
report of the same name.\]

**[Pamphlets]{.underline}**

American Chemical Society. 1988. *Chemical Risk Communication: Preparing
for Community Interest in Chemical Release Data*. American Chemical
Society: Washington.

American Chemical Society. 1989. *Chemical Risk: Personal Decisions*.
American Chemical Society: Washington.

MIT Security Studies Progam. 2002. *The Political Science of Agent
Orange.* MIT: Cambridge, MA (SSP Working Paper May 2002).

**[Papers and Letters]{.underline}**

Miike, L.H., C.J. Behney, and M. Gough. 1981. Identifying and regulating
environmental carcinogens: Living with uncertainty. *IDEA The Journal of
Law and Technology 20*:245-268.

Gough, M. 1983. Assessment of technologies for determining cancer risks
from the environment. *J. Am. College Toxicol. 2*:19-31.

Gough, M. and H. Gelband. 1983. U.S. cancer trends. *Nature 296*:598
\[letter\].

Gough, M. 1983. Laws for the regulation of carcinogens: Identifying and
estimating the risks that the laws seek to reduce. *Toxic Substances J*.
4:251-276.

Gough, M. and H. Gelband. 1983. Congressionally mandated review of an
Agent Orange epidemiology study. *The Sorcerer\'s Apprentice 3*:19-22.

Gough, M. 1983. Alice Hamilton and the conquest of occupational lead
poisoning. *ChemMatters* \[An American Chemical Society publication for
high school students\] December 1983.

Gough, M. 1984. Sources and interpretations of asbestos exposure data.
*J. Toxicology-Clinical Toxicology 21* (1):211.

Gough, M. 1985. Dioxin exposure at Monsanto. *Nature 318*:404.
\[letter\].

Gough, M. 1987. Environmental epidemiology: Separating science from
politics. *Issues in Science and Technology 3*:21-30.

Gough, M. 1988. From plant hormones to Agent Orange. *ChemMatters*
(February 1988).

Gough, M. 1988. Past war: Future risk? *ChemMatters* (April 1988).

Gough, M. 1988. Uncle Sam flunks asbestos control in schools. *Issues in
Science and Technology 4*:81-85.

Scofield, R., R. Powell, M. Conklin, R. Machado, S. Youngren, E.
Fechner, M. Gough, and R. Tardiff. 1988. Multipathway risk assessment
methodology compatible with California Decision Tree and EPA Superfund
Guidelines. *Proceedings of the 5th National Conference on Hazardous
Wastes and Hazardous Materials*, pp. 368-372.

Gough, M. 1988. The most potent carcinogen? *Resources 92*: 2-5.

Gough, M. 1988. Science policy choices and estimation of cancer risk
asociated with TCDD. *Risk Analysis 8*:337-342.

Brown, S.L., S.M. Brett, M. Gough, J.V. Rodricks, R.G. Tardiff, and D.
Turnbull. 1988. Review of interspecies risk comparisons. *Reg. Toxicol.
Pharmacol. 8*:191-206.

Fishbein, L., M. Kaplan, and M. Gough. 1988. Fructooligo-saccharides: A
review. *Veterinary and Human Toxicol. 30*:104-107.

Gough, M. 1989. Estimating cancer mortality: Epidemiology and
toxicological methods produce similar assessments. *Environ. Sci. Tech.
23*:925-929.

Gough, M. 1989. Agent Orange studies. *Science 245*:1031 \[letter\].

Gough, M. 1989. Biological processes: Risk/Toxicology. In R.G. Luthry
and M.J. Small (eds.). *Proceedings of the Conference on: Fundamental
Research Directions in Environmental Enginering.* Association of
Environmental Engineering Professors: Pittsburgh.

Gough, M. 1990. How much cancer can EPA regulate away? *Risk Analysis
10*:1-7.

Gough, M. 1990. Environmental exposures and cancer risks. *Toxics Law
Reporter 4*:1249-1251.

Gough, M. 1990. Environmental exposures and cancer risks. *Resources
98*: 9-12.

Gough, M. 1990. Factors to consider in making risk assessments. In R.
Patrick (ed.), *Proceedings of the Fourth National Conference on
Environmental Issues. Solid Waste Management*. Academy of Natural
Sciences: Philadelphia, pp. 265-281.

Gough, M. 1991. Human health effects: What the data indicate. *Science
of the Total Environment 104*:129-158.

Gough, M. 1991. Agent Orange: Exposure and policy. *American Journal of
Public Health 81*:289-290 \[editorial\].

Gough, M. 1991. Human exposure from dioxin in soil\--a meeting report.
*J. Tox. Environ. Health 32*:205-245.

Gough, M. 1991. Risk assessment and the misplaced focus on environmental
cancers. *J. Regulation Social Costs 1*(2):59-80.

Gough, M. 1991. Comments on \"The importance of the technical
characteristics of hazardous materials in considering environmental
risk.\" *Risk Analysis 11*:31-32.

Gough, M. 1991. Reevaluating the risks from dioxin. *J. Regulation
Social Costs 1*(3):5-24.

Gough, M. 1991. Zero risk or acceptable risk. *Amer. Industrial Hygiene
Assoc. J. 52*[:]{.underline}A556-560.

Gough, M. 1991. Asbestos in buildings: The emergence of policy. *Health
Environ. Digest 5*(9):3-5.

Rae, I.D., B.A. Bolto, M. Gough, and A. Smith. 1991. *Report of the
Reference Panel Appointed to Review Studies of the Impact of Nufarm
Limited on the Environment*. Environmental Protection Authority:
Victoria, Queensland, Australia.

Ibrahim, M.A., G.G. Bond, T.A. Burke, P. Cole, F.N. Dost, P.E.
Enterline, M. Gough, R.S. Greenberg, W.E. Halperin, E.E. McConnell, I.C.
Munro, J.A. Swenberg, S.H. Zahm, and J.D. Graham. 1992. Weight of the
evidence in the human carcinogenicity of 2,4-D. *Environ. Health
Perspectives 96*:213-222.

Gough, M. 1992. Chemical risk assessment is not science. *InChemistry*.
December 1992/January 1993, p. 22-26. (*InChemistry* is a publication of
the American Chemical Society for undergraduate students.)

Gough, M. 1993. Letter to the Editor about an article about banning
chlorine in chemistry. *Chem. Eng. News*, May 10, 1993, p. 3.

Gough, L. and M. Gough. 1993. Risky business. *ChemMatters 11*:10-12.

Gough, M. and J. Wilson. 1994. Understanding the relationship between
science and

risk analysis. *AIHC Journal 2* (1):12-15.

Boroush, M. and M. Gough. 1994. Can cohort studies detect any human
cancer excess that may result from exposure to dioxin? Maybe.
*Regulatory Toxicology and Pharmacology 20*:198-210.

Gough, M. 1995. It\'s not science. What can science do about it? *Health
Physics* *71*:275-278.

Gough, M. 1997. Letter about Paul Ehrlich book. *Chemical and
Engineering News*, May 5 (letter).

Gough, M. 1997. The why and wherefore of wireless technology research:
Introduction and perspective. *Human and Ecological Risk Assessment
3:*1-6.

Gough, M. 1998. A few good men. *Scientific American,* November
(letter).

Gough, M. 1999. Cancer Testing. *Technology 6*:23-42.

Gough, M. 1999. J. Watts, TV Asahi and the dioxin report stir up public
anxieties. *Lancet 353*:1337 (letter).

Gough, M. and S. Milloy. 2000. CALUX™ and GC/MS Analysis of TEQ
Contamination for Risk Assessment of Exposure to Dioxins in Ice Cream.
*20th International Symposium on Halogenated Environmental Organic
Pollutants & POPS 48*:320-323.

Gough, M. 2002. **Antagonism \-- No Synergism \-- in Pair-wise Tests of
Carcinogens in Rats.** *Regulatory Toxicology and Pharmacology*
*35*:383-392.

Gough, M. 2003. The limits of science: Dioxin. *Regulatory Toxicology
and Pharmacology 37*: 170-171.

Gough, M. 2003. Review of the book *Human and Ecological Risk
Assessment: Theory and Practice. Regulatory Toxicology and Pharmacology*
*37*: 341-342.

**[Book Chapters]{.underline}**

\"Assessing Cancer Risks.\" In D.M. O\'Brien and D.A. Marchand (eds.).
*The Politics of Technology Assessment*. Lexington Books: Lexington, MA.
1981.

Gough, M. 1984. \"Federal Research Policies Aimed at Reducing Cancer
Risks.\" In P. Deisler (ed.). *Reducing the Carcinogenic Risks in
Industry*. Marcel Dekker: New York. Pp. 67-98.

Gough, M. 1988. \"The Politics of Agent Orange.\" Iin A. Young and G.
Reggiani (eds.). *Agent Orange and Its Associated Dioxin: Assessment of
a Controversy*. Elsevier: New York, Amsterdam. Pp. 181-190.

Gough, M. and D. Turnbull 1991. \"Use of a Threshold Model for the
Estimation of Risk Associated With Exposure to Chlorinated
Dibenzo-p-dioxins and Dibenzofurans.\" In H.A. Hattemer-Frey and C.C.
Travis (eds.). *Health Effects of Municipal Waste Incineration*. CRS
Press: Boca Paton, FL. Pp. 131-146.

Gough, M. 1993. \"Dioxin: Perceptions, Estimates, and Measures.\" In
K.R. Foster, D. Bernstein, and P. Huber (eds). *Phantom Risk: Scientific
Inference and the Law*. MIT Press: Cambridge. Pp. 249-278.

Moore, J.A., R. A. Kimbrough, and M. Gough. 1993. \"The Dioxin TCDD: A
Selective Study of Science and Policy Interaction.\" In M.F. Uman (ed.).
*Keeping Pace with Science and Engineering: Case Studies in
Environmental Regulation.* National Academy Press: Washington. Pp.
221-242.

Gough, M. 1996. "Objective Risk Assessment." In B.R. Cohen, S.J. Milloy,
and S.J. Zrake (ed). *American Values: An Environmental Vision.* EP
Anet: Washington, DC. Pp. 99-108.

Gough, M. 2003. "Introduction: Science, Risk, and Politics." in *The
Alchemy of Policymaking:  Political Manipulation of Science. *George C.
Marshall Institute: Washington, DC \[in press\].

Gough, M. 2003. "The Political Science of Agent Orange and Dioxin." in
*The Alchemy of Policymaking:  Political Manipulation of
Science. *George C. Marshall Institute: Washington, DC \[in press\].

**[Newspaper Articles]{.underline}**

\"Agent Orange on trial.\" *The Washington Times*, September 18, 1990.

\"Y\'s Boys Club gave good life to poor kid.\" *Springfield* (MO)
*News-Leader,* January 22, 1995.

\"The problems with the \'risk assessment process.\'\" *Detroit* (MI)
*News*, June 22, 1995, p. 10A.

"Agent Orange and politics." *Santa Barbara* (CA) *News-Press,* June 29,
1996 .

"Pro and Con: Agent Orange Disease\--Medical Reality or Political Myth:
The president and an election year." *The Hartford* (CN) *Courant,* July
20, 1996.

"Wine and kids: An analysis gone amok." With Sanford L. Weiner, *Chicago
Tribune*, August 6, 1996.

"The EPA's clean air-ogance." With Steven J. Milloy, *Wall Street
Journal,* January 7, 1997.

"Where cancer's decline is bad news." *Waterbury* (CT)
*Republican-American,* February 3, 1997 (and other papers).

"Dithering on thalidomide." *Washington Post*, February 8, 1997
(letter).

"African-American art forces viewer to confront self." *Springfield*
(MO) *News-Leader,* March 15, 1997.

"Does the environment cause cancer?" *Trenton* (NJ) *Times,* April 1,
1997 (and other papers).

"When politics displaces science, and what that costs you." With Michael
Tanner, *Santa Barbara* (CA) *News Press,* April 13, 1997.

"Clinton's smog proposal promises a legacy of high costs and lost
lives." With Kay Jones, *The Detroit News*, June 29, 1997.

"The shuttle, as well as that white elephant of a space station, should
be sold," *The Philadelphia Inquirer*, July 13, 1997.

"Junk science: It's the law." With Steven J. Milloy, *Investor's
Business Daily,* August 25, 1997.

"President's 'heavy' summer reading is a flight into Ehrlich
fantasyland," *Harrisburg* (PA) *Sunday Patriot News*, August 31, 1997
(and other papers).

"Cancer alley myth exploded." *Greenville* (MS) *Delta Democrat Times,*
September 25, 1997.

"Regulation is useless: Don't rely on heavy regulations that will drive
research underground." \[Op-ed opposing regulation of privately funded
cloning research.\] *USA Today*, January 9, 1998.

"An emply uniform." \[Op-ed about the Surgeon General\]. With Steven J.
Milloy, *Wall Street Journal,* February 10, 1998.

"Slippery claims about salamanders." *Washington Times,* February 15,
1998.

"What's the news about cancer rates?" With Peter vanDoren, *Sacramento
Bee* and other papers, April 18, 1998.

"EPA's illusionary claims of protecting health." *Washington Times*, May
17, 1998.

"Freedom of Information Requests." *Science,* 4 December 1998, p. 1823
(letter).

"Birth study unfairly blames pollution." \[Rebuttal of claims that
environmental pollution is causing a reduction in ratio of boy to girl
babies\]. *Wall Street Journal*, February 23, 1999.

"Saving secret science." With Steven Milloy, *New York Post*, March 24,
1999.

"Seeking out illness as a way to survive." \[Comment on statements from
the American Lung Association about how increases in asthma would
increase its funding\]. *Wall Street Journal,* May 5, 1999.

"Extrinsic toxic waste superfund." With Peter VanDoren, *Washington
Times*, July 18, 2002.

**[Cato Publications]{.underline}**

[*Regulation* magazine]{.underline}

"The Environmental Cancer Epidemic That Never Was," with Steven Milloy.
*Regulation*, 1996, Number 2, pp. 18-21.

"The Dioxin Drama," review of *Dying from Dioxin: A Citizen's Guide to
Reclaiming Our Health and Rebuilding Democracy* by Lois Marie Gibbs.
*Regulation*, 1996, Number 2, pp. 78-80.

"EPA's Sham Science Reveals Political Agenda." *Regulation*, 1997,
Winter, pp. 15-16.

"End the Scientific Witch Hunt." *Regulation,* 1997, Spring, pp. 13-14.

\"Environmental Science and Sound Science.\" *Regulation*, 1998, Vol.
21, No. 1, pp. 13-14.

"Where the Boys Are: Sex Ratios and the Environment." *Regulation*,
1998, Vol. 21, No. 4, pp. 15-18.

"Common Sense in an Age of Nonsense," review of *The Corporation Under
Siege: Exploring the Devices Used by Activists and Regulators in the
Non-Risk Society* by Mark Neal and Christie Davies. *Regulation*, 1999,
Vol. 22, No. 3, pp. 55-56.

"Superfund: The High Cost of Environmental Alarmism," review of
*Calculating Risks: The Spatial and Political Dimensions of Hazardous
Waste Policy* by James T. Hamilton and W. Kip Viscusi. *Regulation,*
2000, Vol. 23, No. 2, pp. 58-60.

# Authored Cato reports

Michael Gough and Steven Milloy, "EPA's Cancer Risk Guidelines: Guidance
to Nowhere." *Policy Analysis no. 263* \[Cato Institute: Washington, DC,
1996\].

Michael Gough and Steven Milloy, "Public Access to Federally Funded
Research Data and Government Responsibility," *Policy Analysis no. 366*
\[Cato Institute: Washington, DC, 2000\].

# Edited Cato reports

Cassandra C. Moore, *Haunted Housing* \[Cato Institute: Washington, DC,
1997\].

Noel D. Campbell, "Replace FDA Regulation of Medical Devices with
Third-Party Certification." *Policy Analysis no. 288* \[Cato Institute:
Washington, DC, 1997\].

**[Congressional Testimony]{.underline}**

Testified more than 30 times about subjects ranging from biotechology
and patents through Agent Orange and dioxin and environmental causes of
cancer to the Department of Commerce's "Advanced Technology Program" and
other subjects.

Most recent: "The Importance of Data Access for Science and Governance,"
before the Subcommittee on Government Management, Information, and
Technology, U.S. House of Representatives, July 15, 1999.

**[Published OTA Documents]{.underline}**

[Project Director and Principal Writer]{.underline}

*Technologies for Determining Cancer Risks from the Environment* (1981)

*Information Content of Premanufacture Notices* (1983)

*Preventing Illness and Injury in the Workplace* (1985)

*Technologies for Detecting Heritable Mutations in Human Beings* (1986)

*Impacts of Antibiotic-Resistant Bacteria* (1995)

[Writer of Sections or Chapters]{.underline}

*Cancer Testing Technology and Saccharin* (1977)

*Impacts of Applied Genetics: Microorganisms, Plants, and Animals*
(1981)

*Nonnuclear Industrial Hazardous Waste: Classifying for Hazard
Management* (1981)

*Technology Transfer at the National Institutes of Health* (1982)

*Habitability of the Love Canal Area: An Analysis of the Technical Basis
for the Decision on the Habitability of the Emergency Declaration Area*
(1983)

*Risks to Children in Schools* (1995)

*Examining Control Technology and Regulatory Impacts in Occupational
Safety and Health\--An Appraisal of OSHA\'s Analytical Approach* (1995)

[Supervised]{.underline}

*Biological Rhythms: Implications for the Worker* (1991)

*Biotechnology in a Global Ecomony* (1991)

*Medical Monitoring and Screening in the Workplace: Results of a Survey*
(1991)

*The Biology of Mental Disorders* (1992)

*Identifying and Controlling Pulmonary Toxicants* (1992)

*Cystic Fibrosis and DNA Tests: Implications of Carrier Screening*
(1992)

*Genetic Tests and Health Insurance* (1992)

*Genetic Counseling and Cystic Fibrosis Carrier Screening: Results of a
Survey* (1992)

*The Menopause, Hormone Therapy, and Women\'s Health* (1992)

*Biological Components of Substance Abuse and Addiction* (1993)

*Biomedical Ethics in U.S. Public Policy* (1993)

*Researching Health Risks* (1994)

*Psychiatric Disabilities, Employment and the Americans with
Disabilities Act* (1994)

*Technologies for Understanding the Root Causes of Substance Abuse and
Addiction* (1994)

*Genetics and Mental Illness* (1994)